Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.
about
Multiple Roles of Peroxiredoxins in InflammationAlternatively activated macrophages in types 1 and 2 diabetesTime-Course Study of the Transcriptome of Peripheral Blood Mononuclear Cells (PBMCs) from Sheep Infected with Fasciola hepaticaChitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemiaA prospective view of animal and human FasciolosisHelminth genomics: The implications for human healthA family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptidesCathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulationTegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycansThe beneficial helminth parasite?Characterization of the antioxidant enzyme, thioredoxin peroxidase, from the carcinogenic human liver fluke, Opisthorchis viverrini.Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepaticaSurvey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepaticaInfection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes.Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in miceImmune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepaticaClonorchis sinensis antigens alter hepatic macrophage polarization in vitro and in vivo.Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis.Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligandsThe absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infectionPeritoneal exudate cells from long-lived rats exhibit increased IL-10/IL-1β expression ratio and preserved NO/urea ratio following LPS-stimulation in vitroImmune modulation by helminth parasites of ruminants: implications for vaccine development and host immune competence.In-depth proteomic and glycomic analysis of the adult-stage Cooperia oncophora excretome/secretome.Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouseFasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophagesA novel carboline derivative inhibits nitric oxide formation in macrophages independent of effects on tumor necrosis factor α and interleukin-1β expressionFasciola hepatica vaccine: we may not be there yet but we're on the right roadTranscriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.Comparative transcriptome profiling approach to glean virulence and immunomodulation-related genes of Fasciola hepatica.Interface Molecules of Angiostrongylus cantonensis: Their Role in Parasite Survival and Modulation of Host Defenses.Redox-assisted protein folding systems in eukaryotic parasitesPeroxiredoxins in parasites.Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine modelFasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica
P2860
Q26774287-595773D7-FF08-406A-B5E1-8A29AB3AEA06Q26849454-F1E989BC-51EA-4BAA-911C-D3CD47E73AA4Q27334595-2C041365-D633-4D92-979B-AC9209CBC0FDQ27345437-84CDE7B3-DAF3-42D9-A49F-B3728F828A04Q28067643-E8DFC3A3-56E4-419A-8B8A-1DC93C93C49DQ28476305-653AB4BF-64EE-4415-86E9-47EB00BE7A0CQ28478122-1F4DECCA-7200-4E3D-8C64-06E6088DF055Q28534617-9ADA9DA2-0179-4569-9240-031F640ADDF9Q28551767-AA216687-FA06-4B45-B548-9A50B049C4B5Q29039519-3B0D83AF-F43B-494E-A594-31BD2CEB800AQ33341309-32256D07-0F34-4DA2-AE5E-6C9F0BF203E5Q33455478-F06A8AA9-BEF2-43F8-B1D5-B833F79F606EQ33550595-B8F91D85-7E89-4D13-8152-D21E0C98000EQ33566856-B8325153-374A-4C6F-91E4-7699B8C9820DQ33613852-7B7D5A67-65B3-4252-BA02-D1BAF2C94B90Q33633305-A7253551-FA36-445D-8037-8B2D1687C9FDQ33675810-FFBADB2B-00C8-4409-AECE-54E744BA36A4Q33765735-9283D8D1-2D2B-4AAD-A91D-4C186D6AF4D4Q33769340-E79AFD02-E34F-4538-B565-298D0ECB9CEBQ33877592-647AE89E-0D7D-494A-9D89-F550FD09606DQ33906000-1AC23C04-76B0-4274-816E-ADFCB8490896Q34072227-32BAB79D-0719-412D-B01D-1912CE6DE11DQ34116035-323F5816-490C-4F2B-AEE6-4767BD567E86Q34303779-B20ED2E9-910C-42C6-B1B5-41F1C73314E9Q34360443-63122F10-DEDD-4E80-A7A9-81F56A3F41D2Q34400239-D4DDB263-CE59-4ABD-A571-3FA17704D145Q34595664-9BEB1AA5-5A3C-400A-AB78-9701CA61B3A6Q35073787-9138EECF-C679-424C-AEBF-E972055739F5Q35156421-220AA5FF-A5F3-454D-B949-AFBBC386C18BQ35195502-04043904-72B6-40DC-A021-252C9A3C0FCCQ35246561-82B5C5CE-99C7-4C80-9B68-99E9F9922CD0Q35329011-E863A41B-CFF5-4E8E-BA65-82DF3A6C25A5Q35599483-79AFF76F-F9E0-4F47-95FB-85FC8E99C5E2Q35875174-C9E73C3C-1289-48AC-8360-3963BA9C0DC5Q36026832-5AC91B33-5CEB-4361-B821-62D104D6A360Q36026850-FE060EBB-98AD-47FF-A159-CEF257D2C1BAQ36257836-A78A7C55-95BA-4485-9020-93009F355DA4Q36330066-8204C8F6-9887-4B80-84EC-96EDBF384CC9Q36386873-20383857-18E1-4EAA-B428-FAB03D6A4CECQ36447711-C035E57C-AE6F-46FD-AAC3-D90955795FD0
P2860
Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@ast
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@en
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@nl
type
label
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@ast
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@en
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@nl
prefLabel
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@ast
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@en
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@nl
P2093
P2860
P1476
Thioredoxin peroxidase secrete ...... ive activation of macrophages.
@en
P2093
John P Dalton
Mary Sekiya
Sandra M O'Neill
P2860
P304
P356
10.1128/IAI.73.1.166-173.2005
P407
P577
2005-01-01T00:00:00Z